(Q30107)

Revision as of 21:58, 8 November 2024 by Superraptor (talk | contribs) (‎Added [en] alias: Discontinuing hormonal gender reassignment)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Statements

Discontinuing hormonal gender reassignment: a nationwide register study. (English)
1 reference
With increasing numbers of people seeking medical gender reassignment, the scientific community has become increasingly aware of the issue of detransitioning from social, hormonal or even surgical gender reassignment (GR). (English)
1 reference
This study aimed to assess the proportion of patients who discontinued their established hormonal gender transition and the risk factors for discontinuation. (English)
1 reference
A nationwide register-based follow-up was conducted. (English)
1 reference
Data were analysed via cross-tabulations with chi-square statistics and t tests/ANOVAs. (English)
1 reference
Multivariate analyses were performed via Cox regression, which accounts for differences in follow-up times. (English)
1 reference
Of the 1,359 subjects who had undergone hormonal GR in Finland from 1996 to 2019, 7.9% discontinued their established hormonal treatment during an average follow-up of 8.5 years. (English)
1 reference
The risk for discontinuing hormonal GR was greater among later cohorts. (English)
1 reference
The hazard ratio was 2.7 (95% confidence interval 1.1-6.1) among those who had accessed gender identity services from 2013 to 2019 compared with those who had come to contact from 1996 to 2005. (English)
1 reference
Discontinuing also appeared to be emerging earlier among those who had entered the process in later years. (English)
1 reference
The risk of discontinuing established medical GR has increased alongside the increase in the number of patients seeking and proceeding to medical GR. (English)
1 reference
The threshold to initiate medical GR may have lowered, resulting in a greater risk of unbalanced treatment decisions. (English)
1 reference
Not applicable (the paper does not present a clinical trial). (English)
1 reference
19 August 2024
1 reference
19 August 2024
1 reference
24
1 reference
1
1 reference
566
1 reference
566
1 reference
The authors declare no competing interests. (English)
1 reference